Oppenheimer Lowers Teladoc Health (NYSE:TDOC) Price Target to $21.00

Teladoc Health (NYSE:TDOC) had its target price lowered by equities researchers at Oppenheimer from $26.00 to $21.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the health services provider’s stock. Oppenheimer’s price objective points to a potential upside of 61.04% from the stock’s current price.

Other analysts have also recently issued reports about the stock. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Friday. TD Cowen reduced their target price on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a report on Friday. Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. DA Davidson reduced their price target on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Finally, Citigroup reduced their price target on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $19.67.

Teladoc Health Trading Down 2.2 %

TDOC traded down $0.29 during trading on Friday, hitting $13.04. The company’s stock had a trading volume of 5,062,634 shares, compared to its average volume of 4,764,991. The firm’s 50 day moving average price is $15.17 and its 200-day moving average price is $17.80. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. The stock has a market cap of $2.21 billion, a PE ratio of -9.74 and a beta of 0.94. Teladoc Health has a twelve month low of $12.65 and a twelve month high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the company posted ($0.37) earnings per share. On average, analysts expect that Teladoc Health will post -1.07 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other news, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the transaction, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, COO Michael Willem Waters sold 4,523 shares of the firm’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $86,751.14. Following the completion of the transaction, the chief operating officer now directly owns 38,570 shares of the company’s stock, valued at approximately $739,772.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Laizer Kornwasser sold 7,882 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76. Following the transaction, the insider now directly owns 57,223 shares of the company’s stock, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock worth $2,038,251 in the last 90 days. 1.63% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of TDOC. Parallel Advisors LLC grew its position in shares of Teladoc Health by 14.6% during the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock worth $87,000 after buying an additional 515 shares during the period. M&T Bank Corp grew its holdings in Teladoc Health by 5.5% during the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock valued at $241,000 after purchasing an additional 584 shares during the period. Van ECK Associates Corp grew its holdings in Teladoc Health by 20.3% during the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock valued at $77,000 after purchasing an additional 606 shares during the period. Arizona State Retirement System grew its holdings in Teladoc Health by 1.4% during the third quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider’s stock valued at $866,000 after purchasing an additional 650 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in Teladoc Health by 4.3% during the third quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock valued at $334,000 after purchasing an additional 748 shares during the period. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.